• Edward Belongia MD

  • Director, Center for Clinical Epidemiology & Population Health


    • Center for Clinical Epidemiology & Population Health
    • 1000 North Oak Ave. ML2 Marshfield, WI 54449

Education


1974 to 1978:
BS, Zoology, University of Michigan, Ann Arbor
1978 to 1982:
MD, Michigan State University, East Lansing
1985:
Internal Medicine, University of Wisconsin Hospital and Clinics-Residency, Madison

Work Experience


1988 to 1990:
Epidemic Intelligence Service Officer, Centers for Disease Control and Prevention, U.S. Public Health Service
1990 to 1995:
Public Health Physician, STD Surveillance and Screening Unit, Minnesota Department of Health, Minneapolis
1995 to Present:
Senior Epidemiologist/Director, Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield
2009 to Present:
Adjunct Professor - Department of Population Health Sciences, University of Wisconsin - Madison, Madison

Statement


Dr. Belongia is an infectious disease epidemiologist and Director of the Center for Clinical Epidemiology and Population Health at the Marshfield Clinic Research Institute. He leads a research team that has conducted vaccine safety and influenza vaccine effectiveness research for over 12 years in collaboration with CDC. He completed an internal medicine residency at the University of Wisconsin and served as a CDC Epidemic Intelligence Service (EIS) officer. Dr. Belongia is currently a member of the CDC Advisory Committee on Immunization Practices (ACIP), and an Adjunct Professor at the University of Wisconsin—Madison.


Research Interests


Infectious disease epidemiology
Influenza
RSV
Vaccine effectiveness
Vaccine safety

Select Publications


  • McLean HQ, Peterson SH, King JP, Meece JK, Belongia EA. School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015. Influenza Other Respi Viruses. 2017 May;11(3):220-229.
    PubMed ID: 27885805
  • Caspard H, Gaglani M, Clipper L, Belongia EA, McLean HQ, Griffin MR, Talbot HK, Poehling KA, Peters TR, Veney N, Ambrose CS. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States. VACCINE. 2016 Jan 14;34(1):77-82.
    PubMed ID: 26589519
  • Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016 Aug;16(8):942-951.
    PubMed ID: 27061888
  • Flannery B, Zimmerman RK, Gubareva LV, Garten RJ, Chung JR, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Ohmit SE, Belongia EA, McLean HQ, Gaglani M, Piedra PA, Mishin VP, Chesnokov AP, Spencer S, Thaker SN, Barnes JR, Foust A, Sessions W, Xu X, Katz J, Fry AM. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. J Infect Dis. 2016 May 6;
    PubMed ID: 27190176
  • McLean HQ, Chow BD, VanWormer JJ, King JP, Belongia EA. Effect of Statin Use on Influenza Vaccine Effectiveness. J Infect Dis. 2016 Jul 28;
    PubMed ID: 27471318
  • Simpson MD, Kieke BA, Sundaram ME, McClure DL, Meece JK, Sifakis F, Gasser RA, Belongia EA. Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons. Open Forum Infect Dis.. 2016 Apr;3(2):ofw081.
    PubMed ID: 27419158
  • McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman R, Nowalk M, Raviotta JM, Jackson ML, Jackson L, Ohmit SE, Petrie JG, Monto A, Meece JK, Thaker S, Thaker S, Clippard J, Spencer SM, Fry A, Belongia EA. Influenza Vaccine Effectiveness in the United States During 2012-13: Variable Protection by Age and Virus Type. JOURNAL OF INFECTIOUS DISEASES. 2015 May;211(10):1529-40.
    PubMed ID: 25406334
  • Belongia EA, Sundaram ME, McClure DL, Meece JK, Ferdinands J, VanWormer JJ. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. VACCINE. 2015 Jan;33(1):246-51.
    PubMed ID: 24962752
  • McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich T, Belongia EA. Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons. Clin Infect Dis.. 2014 Nov;59(10):1375-85.
    PubMed ID: 25270645
  • McNeil MM, Gee J, Weintraub E, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, Jackson L, Omer S, Jacobsen SJ, DeStefano F. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. VACCINE. 2014 Sep;32(42):5390-8.
    PubMed ID: 25108215
  • Sundaram ME, Meece JK, Sifakis F, Gasser R, Belongia EA. Medically attended respiratory syncytial virus infections in adults aged >=50 years: clinical characteristics and outcomes. CLINICAL INFECTIOUS DISEASES. 2014 Feb;58(3):342-9.
    PubMed ID: 24265361
  • McLean HQ, Meece JK, Belongia EA. Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness. VACCINE. 2014 Jan;32(4):453-7.
    PubMed ID: 24291201
  • McClure DL, Kieke BA, Sundaram ME, Simpson M, Meece JK, Sifakis F, Gasser R, Belongia EA. Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults =50 years old. PLoS One. 2014 Jul;9(7):e102586.
    PubMed ID: 25025344
  • Kieke AL, Borchardt MA, Kieke BA, Spencer SK, Vandermause MF, Smith KE, Jawahir SL, Belongia EA, Marshfield Enterococcal Study Group. Use of streptogramin growth promoters in poultry and isolation of streptogramin-resistant enterococcus faecium from humans. J Infect Dis. 2006 Nov;194(9):1200-1208.
    PubMed ID: 17041845